Novo Nordisk Ousts CEO as U.S. Rivals Gain Ground, Drug Pipeline Disappoints
Denmark’s pharmaceutical giant navigates leadership shake-up after Wegovy sales falter and investor confidence wanes.
Eli Lilly’s Zepbound Outperforms Novo Nordisk’s Wegovy in Head-to-Head Weight-Loss Trial
Lilly’s Zepbound shows superior results in weight loss, offering a potential edge in the $150 billion obesity drug market.
Novo Nordisk Cuts Sales Forecast Amid U.S. Slowdown, Expects Wegovy Recovery After FDA Crackdown
The Danish drugmaker’s revised outlook eases investor concerns as a looming ban on copycat Wegovy treatments is expected to help regain U.S. market share.
U.S. Pledges $500 Million to Develop Universal Vaccines
The $500 million investment aims to accelerate the development of vaccines capable of combating multiple viral strains, bolstering global health security.
Roche to Invest $50 Billion in U.S., Add 12,000 Jobs as Trade Challenges Mount
Roche’s U.S. expansion builds on decades of engagement in the country, including its ownership of San Francisco-based Genentech, a leading developer of cancer and biotech therapies. The company currently employs over 25,000 people in the U.S., and its new initiatives further deepen that relationship.
With These Funds We can Advance our Platform, Crucially Developing a Service for Children, Young People and their Families and Carers, Expanding our Reach so More People are Able to Get Help Sooner: Dr Melinda Rees
“Since Covid there has been an alarming downturn in children’s mental health, with record numbers of families seeking support. It is in everyone’s best interests to get these families the help they so desperately need and deserve.”
Vitestro Attracts $22M Funding to Revolutionize Healthcare with Autonomous Blood Drawing Technology
Early feedback from hospitals, staff and patients has been overwhelmingly positive, and we are eager to quickly expand our reach and impact globally.
MedTech's Surge: How Innovation is Transforming Patient Care
MedTech maintains a steady pace of change as technology fuels innovation and reshapes healthcare practices.
HHP Enters New Phase of Growth, Promotes Meg Finn to VP of Marketing
“We are incredibly fortunate to have Meg with us, and I look forward to the continued innovation and success her leadership will bring.”